147 related articles for article (PubMed ID: 15450677)
1. Association between a T/C polymorphism in intron 2 of cholesterol 24S-hydroxylase gene and Alzheimer's disease in Chinese.
Wang B; Zhang C; Zheng W; Lu Z; Zheng C; Yang Z; Wang L; Jin F
Neurosci Lett; 2004 Oct; 369(2):104-7. PubMed ID: 15450677
[TBL] [Abstract][Full Text] [Related]
2. Intronic CYP46 polymorphism along with ApoE genotype in sporadic Alzheimer Disease: from risk factors to disease modulators.
Borroni B; Archetti S; Agosti C; Akkawi N; Brambilla C; Caimi L; Caltagirone C; Di Luca M; Padovani A
Neurobiol Aging; 2004 Jul; 25(6):747-51. PubMed ID: 15165699
[TBL] [Abstract][Full Text] [Related]
3. CYP46: a risk factor for Alzheimer's disease or a coincidence?
Golanska E; Hulas-Bigoszewska K; Wojcik I; Rieske P; Styczynska M; Peplonska B; Pfeffer A; Luczywek E; Wasiak B; Gabryelewicz T; Religa D; Chodakowska-Zebrowska M; Barcikowska M; Sobow T; Liberski PP
Neurosci Lett; 2005 Jul 22-29; 383(1-2):105-8. PubMed ID: 15936520
[TBL] [Abstract][Full Text] [Related]
4. Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's disease.
Desai P; DeKosky ST; Kamboh MI
Neurosci Lett; 2002 Aug; 328(1):9-12. PubMed ID: 12123847
[TBL] [Abstract][Full Text] [Related]
5. Lack of association between the CYP46 gene polymorphism and Italian late-onset sporadic Alzheimer's disease.
Tedde A; Rotondi M; Cellini E; Bagnoli S; Muratore L; Nacmias B; Sorbi S
Neurobiol Aging; 2006 May; 27(5):773.e1-773.e3. PubMed ID: 16055229
[TBL] [Abstract][Full Text] [Related]
6. Lack of association of the cholesterol 24-hydroxylase (CYP46) intron 2 polymorphism with Alzheimer's disease.
Ingelsson M; Jesneck J; Irizarry MC; Hyman BT; Rebeck GW
Neurosci Lett; 2004 Sep; 367(2):228-31. PubMed ID: 15331159
[TBL] [Abstract][Full Text] [Related]
7. Genetic association of CYP46 and risk for Alzheimer's disease.
Combarros O; Infante J; Llorca J; Berciano J
Dement Geriatr Cogn Disord; 2004; 18(3-4):257-60. PubMed ID: 15286456
[TBL] [Abstract][Full Text] [Related]
8. Intron 2 (T/C) CYP46 polymorphism is associated with Alzheimer's disease in Chinese patients.
Li Y; Chu LW; Chen YQ; Cheung BM; Leung RY; Yik PY; Ng KM; Mak W; Jin DY; St George-Hyslop P; Song YQ
Dement Geriatr Cogn Disord; 2006; 22(5-6):399-404. PubMed ID: 16960449
[TBL] [Abstract][Full Text] [Related]
9. Increased brain beta-amyloid load, phosphorylated tau, and risk of Alzheimer disease associated with an intronic CYP46 polymorphism.
Papassotiropoulos A; Streffer JR; Tsolaki M; Schmid S; Thal D; Nicosia F; Iakovidou V; Maddalena A; Lütjohann D; Ghebremedhin E; Hegi T; Pasch T; Träxler M; Brühl A; Benussi L; Binetti G; Braak H; Nitsch RM; Hock C
Arch Neurol; 2003 Jan; 60(1):29-35. PubMed ID: 12533085
[TBL] [Abstract][Full Text] [Related]
10. [Correlation of cholesterol 24-hydroxylase and ATP-binding cassette transporter A1 polymorphisms with Alzheimer's disease].
Wang F; Jia JP
Zhonghua Yi Xue Za Zhi; 2007 Mar; 87(9):614-8. PubMed ID: 17550732
[TBL] [Abstract][Full Text] [Related]
11. Polymorphisms of cholesterol metabolism genes CYP46 and ABCA1 and the risk of sporadic Alzheimer's disease in Chinese.
Wang F; Jia J
Brain Res; 2007 May; 1147():34-8. PubMed ID: 17335784
[TBL] [Abstract][Full Text] [Related]
12. Earlier onset of Alzheimer's disease: risk polymorphisms within PRNP, PRND, CYP46, and APOE genes.
Golanska E; Hulas-Bigoszewska K; Sieruta M; Zawlik I; Witusik M; Gresner SM; Sobow T; Styczynska M; Peplonska B; Barcikowska M; Liberski PP; Corder EH
J Alzheimers Dis; 2009; 17(2):359-68. PubMed ID: 19363267
[TBL] [Abstract][Full Text] [Related]
13. Association of CYP46 gene polymorphism with sporadic Alzheimer's disease in Chinese Han populations: a meta-analysis.
Jin C; Zhang F; Zhu J; Yuan J; Xia M; Xu Q; Jiang X; Wu Y; Xu W
Int J Neurosci; 2013 Apr; 123(4):226-32. PubMed ID: 23167762
[TBL] [Abstract][Full Text] [Related]
14. Polymorphism in the cholesterol 24S-hydroxylase gene (CYP46A1) associated with the APOEpsilon3 allele increases the risk of Alzheimer's disease and of mild cognitive impairment progressing to Alzheimer's disease.
Fernández Del Pozo V; Alvarez Alvarez M; Fernández Martínez M; Galdós Alcelay L; Gómez Busto F; Peña JA; Alfonso-Sánchez MA; Zarranz Imirizaldu JJ; de Pancorbo MM
Dement Geriatr Cogn Disord; 2006; 21(2):81-7. PubMed ID: 16340204
[TBL] [Abstract][Full Text] [Related]
15. CYP46 T/C polymorphism is not associated with Alzheimer's dementia in a population from Hungary.
Juhász A; Rimanóczy A; Boda K; Vincze G; Szlávik G; Zana M; Bjelik A; Pákáski M; Bódi N; Palotás A; Janka Z; Kálmán J
Neurochem Res; 2005 Aug; 30(8):943-8. PubMed ID: 16258842
[TBL] [Abstract][Full Text] [Related]
16. The effects of gender and CYP46 and apo E polymorphism on 24S-hydroxycholesterol levels in Alzheimer's patients treated with statins.
Vega GL; Weiner M; Kölsch H; von Bergmann K; Heun R; Lutjohan D; Nguyen A; Moore C
Curr Alzheimer Res; 2004 Feb; 1(1):71-7. PubMed ID: 15975088
[TBL] [Abstract][Full Text] [Related]
17. An intronic CYP46A1 polymorphism is associated with Alzheimer disease in a Chinese Han population.
He XM; Zhang ZX; Zhang JW; Zhou YT; Wu CB; Tang MN; Hong Z
J Mol Neurosci; 2012 Jul; 47(3):514-8. PubMed ID: 22528464
[TBL] [Abstract][Full Text] [Related]
18. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease.
Chalmers KA; Culpan D; Kehoe PG; Wilcock GK; Hughes A; Love S
Neuroreport; 2004 Jan; 15(1):95-8. PubMed ID: 15106838
[TBL] [Abstract][Full Text] [Related]
19. Association of CYP46 intron 2 polymorphism in Finnish Alzheimer's disease samples and a global scale summary.
Helisalmi S; Vepsäläinen S; Koivisto AM; Mannermaa A; Iivonen S; Hiltunen M; Kiviniemi V; Soininen H
J Neurol Neurosurg Psychiatry; 2006 Mar; 77(3):421-2. PubMed ID: 16484661
[No Abstract] [Full Text] [Related]
20. Exclusion of CYP46 and APOM as candidate genes for Alzheimer's disease in a French population.
Kabbara A; Payet N; Cottel D; Frigard B; Amouyel P; Lambert JC
Neurosci Lett; 2004 Jun; 363(2):139-43. PubMed ID: 15172102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
